WHO Director-General Tedros Adhanom Ghebreyesus said in a news briefing on Tuesday that the coronavirus “Found to be safe, effective and quality-assured after two doses of the inactivated vaccine.”
WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) recommends the vaccine for people over the age of 18. Two doses should last between two and four weeks.
Unlike some other vaccines, CoronaVac does not need to be stored at extremely cold temperatures.
“CoronaVac’s easy storage requirements make it very suitable for low-resource settings,” Tedros said. “Now it’s important to get these life-saving devices to the people who need them quickly.”
It is the eighth vaccine to receive emergency use list from WHO including Pfizer/BioNtech, AstraZeneca, Moderna, Jenson (Johnson & Johnson) and Serum Institute of India.
the world needs more food
“The world is in dire need of multiple COVID-19 vaccines to address the massive access disparity around the world,” Mariangela Simo, WHO’s assistant-director-general for access to health products, said in a statement.
“We urge manufacturers to participate in the COVAX facility, share their knowledge and data, and contribute to bringing the epidemic under control.”
China supplies vaccines
Both Sinovac and Sinoform shots are inactivated vaccines, which are lower in efficacy than the mRNA vaccines produced by Pfizer-BioNtech and Moderna.
Unlike their Western counterparts, the two Chinese companies have not released complete data on their final phase clinical trials conducted around the world, which has been criticized by scientists and health experts.
According to Sinopharm and Sinovac, their vaccines received varying efficacy results in trials conducted in different countries, but they all exceeded the WHO’s 50% efficacy limit for emergency use approval.
On Tuesday, China said it had produced the first batch of its SinoPharm vaccines to be distributed to COVAX, according to state media Xinhua. China’s global vaccine sharing plan plans to deliver 10 million doses.
CNN’s James Griffiths contributed reporting.